STABILIZED CHLORITE SOLUTIONS IN COMBINATION WITH FLUROPYRIMIDINES FOR CANCER
    8.
    发明申请
    STABILIZED CHLORITE SOLUTIONS IN COMBINATION WITH FLUROPYRIMIDINES FOR CANCER 审中-公开
    与癌症联合使用的稳定氯化物解决方案

    公开(公告)号:US20130202719A1

    公开(公告)日:2013-08-08

    申请号:US13748931

    申请日:2013-01-24

    申请人: NUVO RESEARCH AG

    IPC分类号: A61K33/20 A61K31/7068

    摘要: Pharmaceutical compositions for treating neoplastic disorders and uses thereof are provided. Said pharmaceutical compositions comprise stabilized chlorite solutions (e.g. WFIO) and a fluoropyrimidine, 5-FU, or a 5-FU prodrug (e.g. capecitabine, doxifluridine, UFT, S-1, or BOF-A2). The use of the above stabilized chlorite solution in combination with a fluoropyrimidine dramatically improves the quality of life index (QOL) of a patient undergoing cancer chemotherapy. Cancers that can be treated include cancers of the pancreas, gastrointestinal, head, neck, and breast.

    摘要翻译: 提供了用于治疗肿瘤性疾病的药物组合物及其用途。 所述药物组合物包含稳定的亚氯酸盐溶液(例如WFIO)和氟嘧啶,5-FU或5-FU前药(例如卡培他滨,多西葫芦,UFT,S-1或BOF-A2)。 使用上述稳定的亚氯酸盐溶液与氟嘧啶联合显着提高了接受癌症化疗的患者的生活质量指数(QOL)。 可治疗的癌症包括胰腺癌,胃肠癌,头颈部癌和乳腺癌。